Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Hyperlipoproteinemias

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 126 articles:
HTML format



Single Articles


    June 2008
  1. THOMPSON GR
    Recommendations for the use of LDL apheresis.
    Atherosclerosis. 2008;198:247-55.
    PubMed     Related articles    Abstract available


    May 2008
  2. BRAUN A , Yesilaltay A, Acton S, Broschat KO, et al
    Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
    Atherosclerosis. 2008;198:77-84.
    PubMed     Related articles    Abstract available


  3. ANUURAD E , Thomas-Geevarghese A, Devaraj S, Albu J, et al
    Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy.
    Atherosclerosis. 2008;198:192-7.
    PubMed     Related articles    Abstract available


  4. GOUNI-BERTHOLD I , Berthold HK, Gylling H, Hallikainen M, et al
    Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
    Atherosclerosis. 2008;198:198-207.
    PubMed     Related articles    Abstract available


  5. NAKAJIMA K , Nakajima Y, Takeichi S, Fujita MQ, et al
    Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Atherosclerosis. 2008;198:237-46.
    PubMed     Related articles    Abstract available


    April 2008
  6. REIMANN M , Schutte AE, Malan L, Huisman HW, et al
    Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis.
    Atherosclerosis. 2008;197:638-45.
    PubMed     Related articles    Abstract available


  7. BO M , Comba M, Canade' A, Brescianini A, et al
    Clinical implications of white-coat effect among patients attending at a lipid clinic.
    Atherosclerosis. 2008;197:904-9.
    PubMed     Related articles    Abstract available


  8. STIRNADEL H , Lin X, Ling H, Song K, et al
    Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
    Atherosclerosis. 2008;197:868-76.
    PubMed     Related articles    Abstract available


  9. MAUSNER-FAINBERG K , Luboshits G, Mor A, Maysel-Auslender S, et al
    The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.
    Atherosclerosis. 2008;197:829-39.
    PubMed     Related articles    Abstract available


  10. KOTSEVA K , Stagmo M, De Bacquer D, De Backer G, et al
    Treatment potential for cholesterol management in patients with coronary heart disease in 15 European countries: findings from the EUROASPIRE II survey.
    Atherosclerosis. 2008;197:710-7.
    PubMed     Related articles    Abstract available


  11. PIRRO M , Schillaci G, Bagaglia F, Menecali C, et al
    Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.
    Atherosclerosis. 2008;197:757-67.
    PubMed     Related articles    Abstract available


  12. VAVERKOVA H , Karasek D, Novotny D, Jackuliakova D, et al
    Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia.
    Atherosclerosis. 2008;197:725-31.
    PubMed     Related articles    Abstract available


  13. SVIRIDOV D , Hoang A, Ooi E, Watts G, et al
    Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.
    Atherosclerosis. 2008;197:732-9.
    PubMed     Related articles    Abstract available


  14. MAKINEN JI , Perheentupa A, Irjala K, Pollanen P, et al
    Endogenous testosterone and serum lipids in middle-aged men.
    Atherosclerosis. 2008;197:688-93.
    PubMed     Related articles    Abstract available


    March 2008
  15. JACOBS F , Van Craeyveld E, Feng Y, Snoeys J, et al
    Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available


  16. DE HAAN W , van der Hoogt CC, Westerterp M, Hoekstra M, et al
    Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    Atherosclerosis. 2008;197:57-63.
    PubMed     Related articles    Abstract available


  17. LEINO-ARJAS P , Kauppila L, Kaila-Kangas L, Shiri R, et al
    Serum lipids in relation to sciatica among Finns.
    Atherosclerosis. 2008;197:43-9.
    PubMed     Related articles    Abstract available


    February 2008
  18. YOKOTE K , Bujo H, Hanaoka H, Shinomiya M, et al
    Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients Collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis preventi
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available


  19. MARTINEZ LR , Miname MH, Bortolotto LA, Chacra AP, et al
    No correlation and low agreement of imaging and inflammatory atherosclerosis' markers in familial hypercholesterolemia.
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available


  20. ALONSO R , Mata N, Castillo S, Fuentes F, et al
    Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors.
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available


  21. IWASE M , Sonoki K, Sasaki N, Ohdo S, et al
    Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
    Atherosclerosis. 2008;196:931-6.
    PubMed     Related articles    Abstract available


  22. SUMNER AE , Cowie CC
    Ethnic differences in the ability of triglyceride levels to identify insulin resistance.
    Atherosclerosis. 2008;196:696-703.
    PubMed     Related articles    Abstract available


    January 2008
  23. ROSENSON RS , Huskin AL, Wolff DA, Helenowski IB, et al
    Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome.
    Atherosclerosis. 2008;.
    PubMed     Related articles    Abstract available


  24. KOH KK , Quon MJ, Waclawiw MA
    Are statins effective for simultaneously treating dyslipidemias and hypertension?
    Atherosclerosis. 2008;196:1-8.
    PubMed     Related articles    Abstract available


  25. PHUNTUWATE W , Suthisisang C, Koanantakul B, Chaloeiphap P, et al
    Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels.
    Atherosclerosis. 2008;196:122-8.
    PubMed     Related articles    Abstract available


  26. ADAMS MR , Anthony MS, Chen H, Clarkson TB, et al
    Replacement of dietary soy protein isolate with concentrates of soy 7S or 11S globulin has minimal or no effects on plasma lipoprotein profiles and biomarkers of coronary risk in monkeys.
    Atherosclerosis. 2008;196:76-80.
    PubMed     Related articles    Abstract available   Free Full Text


  27. JADDOE VW , de Ridder MA, van den Elzen AP, Hofman A, et al
    Maternal smoking in pregnancy is associated with cholesterol development in the offspring: A 27-years follow-up study.
    Atherosclerosis. 2008;196:42-8.
    PubMed     Related articles    Abstract available


  28. MIYAKE Y , Kimura R, Kokubo Y, Okayama A, et al
    Genetic variants in PCSK9 in the Japanese population: rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population.
    Atherosclerosis. 2008;196:29-36.
    PubMed     Related articles    Abstract available


    December 2007
  29. MARTINEZ-HERVAS S , Fandos M, Real JT, Espinosa O, et al
    Insulin resistance and oxidative stress in familial combined hyperlipidemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  30. PITSAVOS C , Skoumas I, Masoura C, Aznaouridis K, et al
    Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  31. VAN HIMBERGEN TM , van Tits LJ, Ter Avest E, Roest M, et al
    Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  32. WRIGHT WT , Young IS, Nicholls DP, Graham CA, et al
    Genetic screening of the LPL gene in hypertriglyceridaemic patients.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


    November 2007
  33. ATTIA N , Ramaharo A, Paul JL, Cambillau M, et al
    Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  34. BOURBON M , Sun XM, Soutar AK
    A rare polymorphism in the low density lipoprotein (LDL) gene that affects mRNA splicing.
    Atherosclerosis. 2007;195:e17-20.
    PubMed     Related articles    Abstract available


    October 2007
  35. MUELLER MA , Beutner F, Teupser D, Ceglarek U, et al
    Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR(-/-) mice despite severe hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  36. PISCIOTTA L , Fasano T, Calabresi L, Bellocchio A, et al
    A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  37. TALMUD PJ
    Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
    Atherosclerosis. 2007;194:287-92.
    PubMed     Related articles    Abstract available


  38. GASPAROVIC J , Basistova Z, Fabryova L, Wsolova L, et al
    Familial defective apolipoprotein B-100 in Slovakia: are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity?
    Atherosclerosis. 2007;194:e95-107.
    PubMed     Related articles    Abstract available


  39. PISCIOTTA L , Fasano T, Bellocchio A, Bocchi L, et al
    Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients.
    Atherosclerosis. 2007;194:e116-22.
    PubMed     Related articles    Abstract available


  40. CUI R , Iso H, Toyoshima H, Date C, et al
    Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study.
    Atherosclerosis. 2007;194:415-20.
    PubMed     Related articles    Abstract available


    September 2007
  41. MASCITELLI L , Pezzetta F
    Does hypercholesterolemia impair left ventricular function?
    Atherosclerosis. 2007;.
    PubMed     Related articles   


  42. PRASAD K
    Regression of hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  43. SANTOS RD , Miname MH, Martinez LR, Rochitte CE, et al
    Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  44. MEUWESE MC , Trip MD, van Wissen S, van Miert JN, et al
    Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  45. MAZOR R , Shurtz-Swirski R, Farah R, Kristal B, et al
    Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  46. KASSIS AN , Marinangeli CP, Jain D, Ebine N, et al
    Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.
    Atherosclerosis. 2007;194:153-8.
    PubMed     Related articles    Abstract available


  47. KOH KK , Quon MJ, Han SH, Ahn JY, et al
    Combined therapy with ramipril and simvastatin has beneficial additive effects on tissue factor activity and prothrombin fragment 1+2 in patients with type 2 diabetes.
    Atherosclerosis. 2007;194:230-7.
    PubMed     Related articles    Abstract available


  48. HURRELL C , Wietlisbach V, Jotterand V, Volet M, et al
    High prevalence of major cardiovascular risk factors in first-degree relatives of individuals with familial premature coronary artery disease--the GENECARD project.
    Atherosclerosis. 2007;194:253-64.
    PubMed     Related articles    Abstract available


    August 2007
  49. BOURBON M , Alves AC, Medeiros AM, Silva S, et al
    Familial hypercholesterolaemia in Portugal.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  50. HOMER VM , Marais AD, Charlton F, Laurie AD, et al
    Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  51. MARAIS AD , Raal FJ, Stein EA, Rader DJ, et al
    A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  52. JUNYENT M , Zambon D, Gilabert R, Cofan M, et al
    Carotid atherosclerosis in familial combined hyperlipidemia associated with the APOB/APOA-I ratio.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  53. STRAWN WB , Ferrario CM
    Angiotensin II AT(1) receptor blockade normalizes CD11b(+) monocyte production in bone marrow of hypercholesterolemic monkeys.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  54. MABUCHI H , Nohara A, Kobayashi J, Kawashiri MA, et al
    Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: A randomized double-blind study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  55. HOOPER AJ , Marais AD, Tanyanyiwa DM, Burnett JR, et al
    The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population.
    Atherosclerosis. 2007;193:445-8.
    PubMed     Related articles    Abstract available


    July 2007
  56. TALINI E , Di Bello V, Bianchi C, Palagi C, et al
    Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  57. CHERFAN P , Tompa A, Wikby A, Lofgren S, et al
    Effects of simvastatin on human T cells in vivo.
    Atherosclerosis. 2007;193:186-92.
    PubMed     Related articles    Abstract available


    May 2007
  58. BLAHA M , Cermanova M, Blaha V, Jarolim P, et al
    Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  59. BENITEZ MB , Cuniberti L, Fornari MC, Rosso LG, et al
    Endothelial and leukocyte adhesion molecules in primary hypertriglyceridemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  60. THOMAS EL , Potter E, Tosi I, Fitzpatrick J, et al
    Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  61. SCHLAICH MP , Oehmer S, Schneider MP, Delles C, et al
    Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Atherosclerosis. 2007;192:155-60.
    PubMed     Related articles    Abstract available


  62. MURDOCH SJ , Boright AP, Paterson AD, Zinman B, et al
    LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.
    Atherosclerosis. 2007;192:138-47.
    PubMed     Related articles    Abstract available


    April 2007
  63. EVANS K , Burdge GC, Wootton SA, Collins JM, et al
    Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  64. CHMIELEWSKI M , Sucajtys-Szulc E, Kossowska E, Swierczynski J, et al
    Increased gene expression of liver SREBP-2 in experimental chronic renal failure.
    Atherosclerosis. 2007;191:326-32.
    PubMed     Related articles    Abstract available


  65. DE PRADA TP , Pozzi AO, Coronado MT, Pounchard MA, et al
    Atherogenesis takes place in cholesterol-fed rabbits when circulating concentrations of endogenous cortisol are increased and inflammation suppressed.
    Atherosclerosis. 2007;191:333-9.
    PubMed     Related articles    Abstract available


  66. MARTINELLI N , Trabetti E, Bassi A, Girelli D, et al
    The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
    Atherosclerosis. 2007;191:409-17.
    PubMed     Related articles    Abstract available


    March 2007
  67. BERNIER L , Boulet L, Roy M, Dufour R, et al
    Two new large deletions in the low density lipoprotein receptor (LDLR) gene not revealed by PCR-based molecular diagnosis of familial hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  68. ALCALA A , Jansen S, Farkouh ME, Morell M, et al
    Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  69. SHI Y , Zhang P, Zhang L, Osman H, et al
    Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
    Atherosclerosis. 2007;191:54-62.
    PubMed     Related articles    Abstract available


  70. MARTINEAU P , Gaw A, de Teresa E, Farsang C, et al
    Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
    Atherosclerosis. 2007;191:135-46.
    PubMed     Related articles    Abstract available


  71. ZHANG B , Bottcher A, Imaizumi S, Noda K, et al
    Relation between charge-based apolipoprotein B-containing lipoprotein subfractions and remnant-like particle cholesterol levels.
    Atherosclerosis. 2007;191:153-61.
    PubMed     Related articles    Abstract available


    February 2007
  72. OTT C , Schlaich MP, Schmidt BM, Titze SI, et al
    Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  73. YOUNG RS , Naseem KM, Pasupathy S, Ahilathirunayagam S, et al
    Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
    Atherosclerosis. 2007;190:452-8.
    PubMed     Related articles    Abstract available


    January 2007
  74. DE VRIES R , Groen AK, Perton FG, Dallinga-Thie GM, et al
    Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  75. SOROKIN A , Brown JL, Thompson PD
    Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  76. ISHINO S , Mukai T, Kume N, Asano D, et al
    Lectin-like oxidized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability-analysis in hypercholesterolemic rabbits.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  77. LEITER LA , Rosenson RS, Stein E, Reckless JP, et al
    Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  78. SAITO Y , Yamada N, Shirai K, Sasaki J, et al
    Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
    Atherosclerosis. 2007;.
    PubMed     Related articles    Abstract available


  79. CHURCH TS , Levine BD, McGuire DK, Lamonte MJ, et al
    Coronary artery calcium score, risk factors, and incident coronary heart disease events.
    Atherosclerosis. 2007;190:224-31.
    PubMed     Related articles    Abstract available


  80. OKAMURA T , Tanaka H, Miyamatsu N, Hayakawa T, et al
    The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort.
    Atherosclerosis. 2007;190:216-23.
    PubMed     Related articles    Abstract available


  81. VAN OOSTROM AJ , Alipour A, Plokker TW, Sniderman AD, et al
    The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers.
    Atherosclerosis. 2007;190:167-73.
    PubMed     Related articles    Abstract available


  82. BOGANI P , Galli C, Villa M, Visioli F, et al
    Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil.
    Atherosclerosis. 2007;190:181-6.
    PubMed     Related articles    Abstract available


    December 2006
  83. AYAORI M , Momiyama Y, Fayad ZA, Yonemura A, et al
    Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  84. CAMPAGNA F , Martino F, Bifolco M, Montali A, et al
    Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: Results of a family and DNA-based screening.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  85. SCHWARTZ IF , Ingbir M, Chernichovski T, Reshef R, et al
    Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  86. PETTERSSON K , Kjerrulf M, Jungersten L, Johansson K, et al
    The new oral immunomodulating drug DiNAC induces brachial artery vasodilatation at rest and during hyperemia in hypercholesterolemic subjects, likely by a nitric oxide-dependent mechanism.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  87. PFISTER SL
    Aortic thromboxane receptor deficiency alters vascular reactivity in cholesterol-fed rabbits.
    Atherosclerosis. 2006;189:358-63.
    PubMed     Related articles    Abstract available


    November 2006
  88. AI M , Tanaka A, Shoji K, Ogita K, et al
    Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  89. BOUHALI T , Brisson D, St-Pierre J, Tremblay G, et al
    Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  90. ARAMBEPOLA C , Farmer AJ, Perera R, Neil HA, et al
    Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  91. TOSI I , Toledo-Leiva P, Neuwirth C, Naoumova RP, et al
    Genetic defects causing familial hypercholesterolaemia: Identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  92. EEFTING D , Schepers A, De Vries MR, Pires NM, et al
    The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


    October 2006
  93. NORATA GD , Grigore L, Raselli S, Redaelli L, et al
    Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  94. BASISTOVA Z , Gasparovic J, Sivakova D, Raslova K, et al
    H3543Y mutation of apoB-100 in patients with phenotype of familial hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   


  95. KITAJIMA S , Jin Y, Koike T, Yu Y, et al
    Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  96. SOLFRIZZI V , Capurso C, Colacicco AM, D'Introno A, et al
    Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2006;188:455-61.
    PubMed     Related articles    Abstract available


    September 2006
  97. NAKAMURA T , Kodama Y, Takano H, Umetani K, et al
    Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   


  98. ZHU XY , Daghini E, Rodriguez-Porcel M, Chade AR, et al
    Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  99. PUCCI A , Sheiban I, Formato L, Celeste A, et al
    In vivo coronary plaque histology in patients with stable and acute coronary syndromes Relationships with hyperlipidemic status and statin treatment.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  100. PRASAD K , Lee P
    Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  101. GONZALEZ-SANTIAGO M , Martin-Bautista E, Carrero JJ, Fonolla J, et al
    One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development.
    Atherosclerosis. 2006;188:35-42.
    PubMed     Related articles    Abstract available


  102. FLOREZ H , Mendez A, Casanova-Romero P, Larreal-Urdaneta C, et al
    Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.
    Atherosclerosis. 2006;188:134-41.
    PubMed     Related articles    Abstract available


    August 2006
  103. GOSSL M , Versari D, Mannheim D, Ritman EL, et al
    Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia-Implications for vulnerable plaque-development.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  104. HAKIMOGLU F , Kizil G, Kanay Z, Kizil M, et al
    The effect of ethanol extract of Hypericum lysimachioides on lipid profile in hypercholesterolemic rabbits and its in vitro antioxidant activity.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  105. BUDOFF MJ , Nasir K, Mao S, Tseng PH, et al
    Ethnic differences of the presence and severity of coronary atherosclerosis.
    Atherosclerosis. 2006;187:343-50.
    PubMed     Related articles    Abstract available


    July 2006
  106. MAAS R , Quitzau K, Schwedhelm E, Spieker L, et al
    Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  107. STEEN H , Kolmakova A, Stuber M, Rodriguez ER, et al
    MRI visualized neo-intimal dissection and co-localization of novel apoptotic markers apolipoprotein C-1, ceramide and caspase-3 in a Watanabe hyperlipidemic rabbit model.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  108. LOBODA A , Jazwa A, Jozkowicz A, Dorosz J, et al
    Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.
    Atherosclerosis. 2006;187:26-30.
    PubMed     Related articles    Abstract available   Free Full Text


  109. ROSENBLAT M , Karry R, Aviram M
    Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Atherosclerosis. 2006;187:74-81.
    PubMed     Related articles    Abstract available


    June 2006
  110. SHANMUGANAYAGAM D , Warner TF, Krueger CG, Reed JD, et al
    Concord grape juice attenuates platelet aggregation, serum cholesterol and development of atheroma in hypercholesterolemic rabbits.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  111. HENNEMAN P , Schaap FG, Havekes LM, Rensen PC, et al
    Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  112. OIKAWA S , Kita T, Mabuchi H, Matsuzaki M, et al
    Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: Implication from Japan Lipid Intervention Trial (J-LIT).
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


    May 2006
  113. GRAHAM CA , Wright WT, McIlhatton BP, Young IS, et al
    The LDLR variant T705I does not cause the typical phenotype of familial hypercholesterolaemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   


  114. OLIVA CP , Pisciotta L, Guardamagna O, Bellocchio A, et al
    A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia.
    Atherosclerosis. 2006;.
    PubMed     Related articles   


  115. TER AVEST E , Holewijn S, Bredie SJ, Stalenhoef AF, et al
    Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH).
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  116. SKILTON MR , Moulin P, Serusclat A, Nony P, et al
    A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  117. CORTI R , Osende J, Hutter R, Viles-Gonzalez JF, et al
    Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: In vivo demonstration by high-resolution MRI.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  118. NAISSIDES M , Mamo JC, James AP, Pal S, et al
    The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women.
    Atherosclerosis. 2006;185:438-45.
    PubMed     Related articles    Abstract available


    March 2006
  119. HOGUE JC , Lamarche B, Gaudet D, Tremblay AJ, et al
    Association of heterozygous familial hypercholesterolemia with smaller HDL particle size.
    Atherosclerosis. 2006;.
    PubMed     Related articles    Abstract available


  120. ERHARDT LR , Gotto A Jr
    The evolution of European guidelines: changing the management of cholesterol levels.
    Atherosclerosis. 2006;185:12-20.
    PubMed     Related articles    Abstract available


  121. LAAKSONEN R , Thelen KM, Paiva H, Matinheikki J, et al
    Genetic variant of the SREBF-1 gene is significantly related to cholesterol synthesis in man.
    Atherosclerosis. 2006;185:206-9.
    PubMed     Related articles    Abstract available


    February 2006
  122. HOENIG MR , Rolfe BE, Campbell JH
    Cholestanol: a serum marker to guide LDL cholesterol-lowering therapy.
    Atherosclerosis. 2006;184:247-54.
    PubMed     Related articles    Abstract available


  123. KOSUGE K , Miida T, Takahashi A, Obayashi K, et al
    Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations.
    Atherosclerosis. 2006;184:413-9.
    PubMed     Related articles    Abstract available


  124. TAN KC , Chow WS, Lam JC, Lam B, et al
    HDL dysfunction in obstructive sleep apnea.
    Atherosclerosis. 2006;184:377-82.
    PubMed     Related articles    Abstract available


    January 2006
  125. BOUDIK F , Reissigova J, Hrach K, Tomeckova M, et al
    Primary prevention of coronary artery disease among middle aged men in Prague: twenty-year follow-up results.
    Atherosclerosis. 2006;184:86-93.
    PubMed     Related articles    Abstract available


  126. PEREIRA AC , Sposito AC, Mota GF, Cunha RS, et al
    Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: new evidence for a direct effect of lipids in arterial blood pressure.
    Atherosclerosis. 2006;184:193-200.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: